Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Osman Bilge Kaya
Observed names:
Kaya, Osman Bilge,
Kaya, Osman bilge,
OSMAN BILGE KAYA,
Osman Kaya
Institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital,
Ankara Eğitim ve Araştırma Hastanesi
Observed institutions:
Ankara Onkoloji Eğitim ve Araştırma Hastanesi,
Sağlık Bilimleri Üniversitesi,
Ankara Dr. Abdurrahman Yurtaslan Oncology Training and Research Hospital,
Ankara Eğitim ve Araştırma Hastanesi
ORCID:
0000-0002-9795-8631
Observed ORCID:
0000-0002-9795-8631
OpenAlex ID:
A5093995383
The Role of Artificial Intelligence (ChatGPT-4o) in Supporting Tumor Board Decisions
2025
·
Berkan Karabuğa
, Cengiz Karaçin
, et al.
·
Journal of Clinical Medicine
·
23
PDF
Confounding-aware disproportionality analysis reveals disease-inherent versus drug-attributable endocrine safety signals of immune checkpoint inhibitors
2026
·
Osman Bilge Kaya
, Refika Yorulmaz Kaya
·
Frontiers in Pharmacology
·
2
PDF
Large Language Models as Decision-support Tools for Adjuvant Therapy Planning in Early-stage Hormone Receptor–positive Breast Cancer
2026
·
BERKAN KARABUĞA
, MUSTAFA BÜYÜKKÖR
, et al.
·
Cancer Diagnosis & Prognosis
·
2
PDF
Does Time to Treatment Failure Measure the Same Clinical Process Across Oncology Facilities? Comment on Kajiura et al. Facility-Level Medical Oncology Specialist Availability and First-Line Time to Treatment Failure in Lung Cancer: A Nationwide C-CAT Registry Analysis. Curr. Oncol. 2026, 33, 462
2026
·
Berkan Karabuga
, Ekin Konca Karabuga
, et al.
·
Current Oncology
·
1
Corrected calcium as a predictor of short-term mortality in patients hospitalized with cancer-related hypercalcemia
2025
·
Berkan Karabuğa
, Mustafa Büyükkör
, et al.
·
Journal of Medicine and Palliative Care
·
1
PDF
Mucosal, Ocular, and Pulmonary Adverse Events Reported with Datopotamab Deruxtecan: An Indication-Restricted Disproportionality Analysis of the FDA Adverse Event Reporting System
2026
·
Osman Bilge Kaya
, Berkan Karabuğa
, et al.
·
Pharmaceuticals
Distinct NGS mutational landscape and prognostic implications in early-onset colorectal cancer: A dual-cohort analysis of TCGA PanCancer Atlas and MSK-IMPACT 50K
2026
·
Elif Sertesen Çamöz
, Osman Bilge Kaya
, et al.
·
PLoS ONE
PDF
How much can ASTRUM-006 tell us?
2026
·
Osman Bilge Kaya
, Berkan Karabuğa
·
The Lancet
Absolute Survival Benefit of Daraxonrasib in Previously Treated Metastatic Pancreatic Cancer: A Reconstructed Individual Patient Data Re-analysis of RASolute 302
2026
·
Kaya, Osman Bilge
, Karabuğa, Berkan
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Analysis code for "Mucosal, ocular and pulmonary adverse events reported with datopotamab deruxtecan: an indication-restricted disproportionality analysis of the FDA Adverse Event Reporting"
2026
·
Kaya, Osman Bilge
, Karabuğa, Berkan
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
Interpretation of the BRIGHT-2 Trial
2026
·
Osman Bilge Kaya
, Berkan Karabuga
, et al.
·
JAMA Oncology
Influence of bone metastases on presentation and management of malignant hypercalcemia: a single-center cohort
2026
·
Ergin Aydemir
, Ayşe Ocak Duran
, et al.
·
Anatolian Current Medical Journal
PDF
From the stands to survival fandom, a psychosocial force in the fight against cancer
2026
·
Berkan Karabuğa
, Ekin Konca Karabuğa
, et al.
·
Journal of Health Psychology
Proteogenomic and single-cell dissection of immune heterogeneity in NSMP endometrial cancer reveals dual IDO1 programs
2026
·
Osman Bilge Kaya
, Berkan Karabuğa
, et al.
·
Research Square
PDF
Analysis code for "Proteogenomic and single-cell dissection of immune heterogeneity in NSMP endometrial cancer reveals dual IDO1 programs"
2026
·
Kaya, Osman bilge
, Karabuga, Berkan
, et al.
·
Zenodo (CERN European Organization for Nuclear Research)
A novel inflammation and tumor marker‑based prognostic score, neutrophil‑lymphocyte ratio‑C‑reactive protein‑Ca19‑9, in metastatic gastric cancer
2026
·
Berkan Karabuğa
, Osman Kaya
, et al.
·
Oncology Letters
PDF
Neutropenia and G-CSF use in patients receiving FOLFOX during the COVID-19 pandemic
2026
·
Berkan Karabuğa
, Hatice Gülgün Fırat
, et al.
·
Journal of Oncology Pharmacy Practice
HALP and SII as blood-based predictors in metastatic small-cell lung cancer
2026
·
Berkan Karabuğa
, Mehmet Emin Yılmaz
, et al.
·
Anatolian Current Medical Journal
PDF
Impact of Tissue Lipocalin-2 Expression on Pathologic Response and Prognosis Following Neoadjuvant Chemotherapy in Locally Advanced Triple-Negative Breast Cancer
2026
·
Mehmet Emin Yılmaz
, Öztürk Ateş
, et al.
·
Eurasian Journal of Medical Advances
PDF
Kanser Hastalarının Başvurduğu Geleneksel ve Tamamlayıcı Tedaviler - Tıbbi Onkolog Gözü ile Bakış ve Onkolojik İlaçlarla Etkileşim
2024
·
Ayşegül Sakin
, Kubilay Karaboyun
, et al.
·
Akademisyen Kitabevi eBooks
PDF
Akdeniz Diyeti
2024
·
Osman Bilge Kaya
·
Akademisyen Kitabevi eBooks
Gastrointestinal Sistemde Temel Semiyoloji
2022
·
Eyyüp Taşdemir
, Feridun Gürlek
, et al.
·
Akademisyen Kitabevi eBooks
PDF
Show more works
View as search
Works count:
22
Citation count:
29
H-index:
2
I10-index:
1
Year
Topic
Type